Global CD30 (TNFRSF8) Protein Market Growth 2022-2028
CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor (TNFR) superfamily. CD30 can regulate proliferation of lymphocytes and may also play an important role in human immunodeficiency virus replication.
The global market for CD30 (TNFRSF8) Protein is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC CD30 (TNFRSF8) Protein market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States CD30 (TNFRSF8) Protein market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe CD30 (TNFRSF8) Protein market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China CD30 (TNFRSF8) Protein market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key CD30 (TNFRSF8) Protein players cover Sino Biological, Inc., Bio-Techne, Elabscience Biotechnology Inc., Abbexa and MyBiosource, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global CD30 (TNFRSF8) Protein market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global CD30 (TNFRSF8) Protein market, with both quantitative and qualitative data, to help readers understand how the CD30 (TNFRSF8) Protein market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the CD30 (TNFRSF8) Protein market and forecasts the market size by Type (Purity : Greater Than 85%, Purity : Greater Than 90% and Purity : Greater Than 95%), by Application (SDS-PAGE, ELISA and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Purity : Greater Than 85%
Purity : Greater Than 90%
Purity : Greater Than 95%
Purity : Greater Than 97%
Other
Segmentation by application
SDS-PAGE
ELISA
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Sino Biological, Inc.
Bio-Techne
Elabscience Biotechnology Inc.
Abbexa
MyBiosource, Inc.
OriGene Technologies, Inc.
Prospec-Tany Technogene Ltd.
KACTUS
G&P Biosciences
ACROBiosystems
Assay Genie
ZellBio GmbH
Chapter Introduction
Chapter 1: Scope of CD30 (TNFRSF8) Protein, Research Methodology, etc.
Chapter 2: Executive Summary, global CD30 (TNFRSF8) Protein market size (sales and revenue) and CAGR, CD30 (TNFRSF8) Protein market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: CD30 (TNFRSF8) Protein sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global CD30 (TNFRSF8) Protein sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global CD30 (TNFRSF8) Protein market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Sino Biological, Inc., Bio-Techne, Elabscience Biotechnology Inc., Abbexa, MyBiosource, Inc., OriGene Technologies, Inc., Prospec-Tany Technogene Ltd., KACTUS and G&P Biosciences, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CD30 (TNFRSF8) Protein Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for CD30 (TNFRSF8) Protein by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for CD30 (TNFRSF8) Protein by Country/Region, 2017, 2022 & 2028
2.2 CD30 (TNFRSF8) Protein Segment by Type
2.2.1 Purity : Greater Than 85%
2.2.2 Purity : Greater Than 90%
2.2.3 Purity : Greater Than 95%
2.2.4 Purity : Greater Than 97%
2.2.5 Other
2.3 CD30 (TNFRSF8) Protein Sales by Type
2.3.1 Global CD30 (TNFRSF8) Protein Sales Market Share by Type (2017-2022)
2.3.2 Global CD30 (TNFRSF8) Protein Revenue and Market Share by Type (2017-2022)
2.3.3 Global CD30 (TNFRSF8) Protein Sale Price by Type (2017-2022)
2.4 CD30 (TNFRSF8) Protein Segment by Application
2.4.1 SDS-PAGE
2.4.2 ELISA
2.4.3 Other
2.5 CD30 (TNFRSF8) Protein Sales by Application
2.5.1 Global CD30 (TNFRSF8) Protein Sale Market Share by Application (2017-2022)
2.5.2 Global CD30 (TNFRSF8) Protein Revenue and Market Share by Application (2017-2022)
2.5.3 Global CD30 (TNFRSF8) Protein Sale Price by Application (2017-2022)
3 Global CD30 (TNFRSF8) Protein by Company
3.1 Global CD30 (TNFRSF8) Protein Breakdown Data by Company
3.1.1 Global CD30 (TNFRSF8) Protein Annual Sales by Company (2020-2022)
3.1.2 Global CD30 (TNFRSF8) Protein Sales Market Share by Company (2020-2022)
3.2 Global CD30 (TNFRSF8) Protein Annual Revenue by Company (2020-2022)
3.2.1 Global CD30 (TNFRSF8) Protein Revenue by Company (2020-2022)
3.2.2 Global CD30 (TNFRSF8) Protein Revenue Market Share by Company (2020-2022)
3.3 Global CD30 (TNFRSF8) Protein Sale Price by Company
3.4 Key Manufacturers CD30 (TNFRSF8) Protein Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers CD30 (TNFRSF8) Protein Product Location Distribution
3.4.2 Players CD30 (TNFRSF8) Protein Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for CD30 (TNFRSF8) Protein by Geographic Region
4.1 World Historic CD30 (TNFRSF8) Protein Market Size by Geographic Region (2017-2022)
4.1.1 Global CD30 (TNFRSF8) Protein Annual Sales by Geographic Region (2017-2022)
4.1.2 Global CD30 (TNFRSF8) Protein Annual Revenue by Geographic Region
4.2 World Historic CD30 (TNFRSF8) Protein Market Size by Country/Region (2017-2022)
4.2.1 Global CD30 (TNFRSF8) Protein Annual Sales by Country/Region (2017-2022)
4.2.2 Global CD30 (TNFRSF8) Protein Annual Revenue by Country/Region
4.3 Americas CD30 (TNFRSF8) Protein Sales Growth
4.4 APAC CD30 (TNFRSF8) Protein Sales Growth
4.5 Europe CD30 (TNFRSF8) Protein Sales Growth
4.6 Middle East & Africa CD30 (TNFRSF8) Protein Sales Growth
5 Americas
5.1 Americas CD30 (TNFRSF8) Protein Sales by Country
5.1.1 Americas CD30 (TNFRSF8) Protein Sales by Country (2017-2022)
5.1.2 Americas CD30 (TNFRSF8) Protein Revenue by Country (2017-2022)
5.2 Americas CD30 (TNFRSF8) Protein Sales by Type
5.3 Americas CD30 (TNFRSF8) Protein Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CD30 (TNFRSF8) Protein Sales by Region
6.1.1 APAC CD30 (TNFRSF8) Protein Sales by Region (2017-2022)
6.1.2 APAC CD30 (TNFRSF8) Protein Revenue by Region (2017-2022)
6.2 APAC CD30 (TNFRSF8) Protein Sales by Type
6.3 APAC CD30 (TNFRSF8) Protein Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe CD30 (TNFRSF8) Protein by Country
7.1.1 Europe CD30 (TNFRSF8) Protein Sales by Country (2017-2022)
7.1.2 Europe CD30 (TNFRSF8) Protein Revenue by Country (2017-2022)
7.2 Europe CD30 (TNFRSF8) Protein Sales by Type
7.3 Europe CD30 (TNFRSF8) Protein Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CD30 (TNFRSF8) Protein by Country
8.1.1 Middle East & Africa CD30 (TNFRSF8) Protein Sales by Country (2017-2022)
8.1.2 Middle East & Africa CD30 (TNFRSF8) Protein Revenue by Country (2017-2022)
8.2 Middle East & Africa CD30 (TNFRSF8) Protein Sales by Type
8.3 Middle East & Africa CD30 (TNFRSF8) Protein Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of CD30 (TNFRSF8) Protein
10.3 Manufacturing Process Analysis of CD30 (TNFRSF8) Protein
10.4 Industry Chain Structure of CD30 (TNFRSF8) Protein
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 CD30 (TNFRSF8) Protein Distributors
11.3 CD30 (TNFRSF8) Protein Customer
12 World Forecast Review for CD30 (TNFRSF8) Protein by Geographic Region
12.1 Global CD30 (TNFRSF8) Protein Market Size Forecast by Region
12.1.1 Global CD30 (TNFRSF8) Protein Forecast by Region (2023-2028)
12.1.2 Global CD30 (TNFRSF8) Protein Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global CD30 (TNFRSF8) Protein Forecast by Type
12.7 Global CD30 (TNFRSF8) Protein Forecast by Application
13 Key Players Analysis
13.1 Sino Biological, Inc.
13.1.1 Sino Biological, Inc. Company Information
13.1.2 Sino Biological, Inc. CD30 (TNFRSF8) Protein Product Offered
13.1.3 Sino Biological, Inc. CD30 (TNFRSF8) Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sino Biological, Inc. Main Business Overview
13.1.5 Sino Biological, Inc. Latest Developments
13.2 Bio-Techne
13.2.1 Bio-Techne Company Information
13.2.2 Bio-Techne CD30 (TNFRSF8) Protein Product Offered
13.2.3 Bio-Techne CD30 (TNFRSF8) Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bio-Techne Main Business Overview
13.2.5 Bio-Techne Latest Developments
13.3 Elabscience Biotechnology Inc.
13.3.1 Elabscience Biotechnology Inc. Company Information
13.3.2 Elabscience Biotechnology Inc. CD30 (TNFRSF8) Protein Product Offered
13.3.3 Elabscience Biotechnology Inc. CD30 (TNFRSF8) Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Elabscience Biotechnology Inc. Main Business Overview
13.3.5 Elabscience Biotechnology Inc. Latest Developments
13.4 Abbexa
13.4.1 Abbexa Company Information
13.4.2 Abbexa CD30 (TNFRSF8) Protein Product Offered
13.4.3 Abbexa CD30 (TNFRSF8) Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Abbexa Main Business Overview
13.4.5 Abbexa Latest Developments
13.5 MyBiosource, Inc.
13.5.1 MyBiosource, Inc. Company Information
13.5.2 MyBiosource, Inc. CD30 (TNFRSF8) Protein Product Offered
13.5.3 MyBiosource, Inc. CD30 (TNFRSF8) Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 MyBiosource, Inc. Main Business Overview
13.5.5 MyBiosource, Inc. Latest Developments
13.6 OriGene Technologies, Inc.
13.6.1 OriGene Technologies, Inc. Company Information
13.6.2 OriGene Technologies, Inc. CD30 (TNFRSF8) Protein Product Offered
13.6.3 OriGene Technologies, Inc. CD30 (TNFRSF8) Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 OriGene Technologies, Inc. Main Business Overview
13.6.5 OriGene Technologies, Inc. Latest Developments
13.7 Prospec-Tany Technogene Ltd.
13.7.1 Prospec-Tany Technogene Ltd. Company Information
13.7.2 Prospec-Tany Technogene Ltd. CD30 (TNFRSF8) Protein Product Offered
13.7.3 Prospec-Tany Technogene Ltd. CD30 (TNFRSF8) Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Prospec-Tany Technogene Ltd. Main Business Overview
13.7.5 Prospec-Tany Technogene Ltd. Latest Developments
13.8 KACTUS
13.8.1 KACTUS Company Information
13.8.2 KACTUS CD30 (TNFRSF8) Protein Product Offered
13.8.3 KACTUS CD30 (TNFRSF8) Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 KACTUS Main Business Overview
13.8.5 KACTUS Latest Developments
13.9 G&P Biosciences
13.9.1 G&P Biosciences Company Information
13.9.2 G&P Biosciences CD30 (TNFRSF8) Protein Product Offered
13.9.3 G&P Biosciences CD30 (TNFRSF8) Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 G&P Biosciences Main Business Overview
13.9.5 G&P Biosciences Latest Developments
13.10 ACROBiosystems
13.10.1 ACROBiosystems Company Information
13.10.2 ACROBiosystems CD30 (TNFRSF8) Protein Product Offered
13.10.3 ACROBiosystems CD30 (TNFRSF8) Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 ACROBiosystems Main Business Overview
13.10.5 ACROBiosystems Latest Developments
13.11 Assay Genie
13.11.1 Assay Genie Company Information
13.11.2 Assay Genie CD30 (TNFRSF8) Protein Product Offered
13.11.3 Assay Genie CD30 (TNFRSF8) Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Assay Genie Main Business Overview
13.11.5 Assay Genie Latest Developments
13.12 ZellBio GmbH
13.12.1 ZellBio GmbH Company Information
13.12.2 ZellBio GmbH CD30 (TNFRSF8) Protein Product Offered
13.12.3 ZellBio GmbH CD30 (TNFRSF8) Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 ZellBio GmbH Main Business Overview
13.12.5 ZellBio GmbH Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. CD30 (TNFRSF8) Protein Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. CD30 (TNFRSF8) Protein Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Purity : Greater Than 85%
Table 4. Major Players of Purity : Greater Than 90%
Table 5. Major Players of Purity : Greater Than 95%
Table 6. Major Players of Purity : Greater Than 97%
Table 7. Major Players of Other
Table 8. Global CD30 (TNFRSF8) Protein Sales by Type (2017-2022) & (K Units)
Table 9. Global CD30 (TNFRSF8) Protein Sales Market Share by Type (2017-2022)
Table 10. Global CD30 (TNFRSF8) Protein Revenue by Type (2017-2022) & ($ million)
Table 11. Global CD30 (TNFRSF8) Protein Revenue Market Share by Type (2017-2022)
Table 12. Global CD30 (TNFRSF8) Protein Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global CD30 (TNFRSF8) Protein Sales by Application (2017-2022) & (K Units)
Table 14. Global CD30 (TNFRSF8) Protein Sales Market Share by Application (2017-2022)
Table 15. Global CD30 (TNFRSF8) Protein Revenue by Application (2017-2022)
Table 16. Global CD30 (TNFRSF8) Protein Revenue Market Share by Application (2017-2022)
Table 17. Global CD30 (TNFRSF8) Protein Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global CD30 (TNFRSF8) Protein Sales by Company (2020-2022) & (K Units)
Table 19. Global CD30 (TNFRSF8) Protein Sales Market Share by Company (2020-2022)
Table 20. Global CD30 (TNFRSF8) Protein Revenue by Company (2020-2022) ($ Millions)
Table 21. Global CD30 (TNFRSF8) Protein Revenue Market Share by Company (2020-2022)
Table 22. Global CD30 (TNFRSF8) Protein Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers CD30 (TNFRSF8) Protein Producing Area Distribution and Sales Area
Table 24. Players CD30 (TNFRSF8) Protein Products Offered
Table 25. CD30 (TNFRSF8) Protein Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global CD30 (TNFRSF8) Protein Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global CD30 (TNFRSF8) Protein Sales Market Share Geographic Region (2017-2022)
Table 30. Global CD30 (TNFRSF8) Protein Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global CD30 (TNFRSF8) Protein Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global CD30 (TNFRSF8) Protein Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global CD30 (TNFRSF8) Protein Sales Market Share by Country/Region (2017-2022)
Table 34. Global CD30 (TNFRSF8) Protein Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global CD30 (TNFRSF8) Protein Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas CD30 (TNFRSF8) Protein Sales by Country (2017-2022) & (K Units)
Table 37. Americas CD30 (TNFRSF8) Protein Sales Market Share by Country (2017-2022)
Table 38. Americas CD30 (TNFRSF8) Protein Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas CD30 (TNFRSF8) Protein Revenue Market Share by Country (2017-2022)
Table 40. Americas CD30 (TNFRSF8) Protein Sales by Type (2017-2022) & (K Units)
Table 41. Americas CD30 (TNFRSF8) Protein Sales Market Share by Type (2017-2022)
Table 42. Americas CD30 (TNFRSF8) Protein Sales by Application (2017-2022) & (K Units)
Table 43. Americas CD30 (TNFRSF8) Protein Sales Market Share by Application (2017-2022)
Table 44. APAC CD30 (TNFRSF8) Protein Sales by Region (2017-2022) & (K Units)
Table 45. APAC CD30 (TNFRSF8) Protein Sales Market Share by Region (2017-2022)
Table 46. APAC CD30 (TNFRSF8) Protein Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC CD30 (TNFRSF8) Protein Revenue Market Share by Region (2017-2022)
Table 48. APAC CD30 (TNFRSF8) Protein Sales by Type (2017-2022) & (K Units)
Table 49. APAC CD30 (TNFRSF8) Protein Sales Market Share by Type (2017-2022)
Table 50. APAC CD30 (TNFRSF8) Protein Sales by Application (2017-2022) & (K Units)
Table 51. APAC CD30 (TNFRSF8) Protein Sales Market Share by Application (2017-2022)
Table 52. Europe CD30 (TNFRSF8) Protein Sales by Country (2017-2022) & (K Units)
Table 53. Europe CD30 (TNFRSF8) Protein Sales Market Share by Country (2017-2022)
Table 54. Europe CD30 (TNFRSF8) Protein Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe CD30 (TNFRSF8) Protein Revenue Market Share by Country (2017-2022)
Table 56. Europe CD30 (TNFRSF8) Protein Sales by Type (2017-2022) & (K Units)
Table 57. Europe CD30 (TNFRSF8) Protein Sales Market Share by Type (2017-2022)
Table 58. Europe CD30 (TNFRSF8) Protein Sales by Application (2017-2022) & (K Units)
Table 59. Europe CD30 (TNFRSF8) Protein Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa CD30 (TNFRSF8) Protein Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa CD30 (TNFRSF8) Protein Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa CD30 (TNFRSF8) Protein Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa CD30 (TNFRSF8) Protein Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa CD30 (TNFRSF8) Protein Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa CD30 (TNFRSF8) Protein Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa CD30 (TNFRSF8) Protein Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa CD30 (TNFRSF8) Protein Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of CD30 (TNFRSF8) Protein
Table 69. Key Market Challenges & Risks of CD30 (TNFRSF8) Protein
Table 70. Key Industry Trends of CD30 (TNFRSF8) Protein
Table 71. CD30 (TNFRSF8) Protein Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. CD30 (TNFRSF8) Protein Distributors List
Table 74. CD30 (TNFRSF8) Protein Customer List
Table 75. Global CD30 (TNFRSF8) Protein Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global CD30 (TNFRSF8) Protein Sales Market Forecast by Region
Table 77. Global CD30 (TNFRSF8) Protein Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global CD30 (TNFRSF8) Protein Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas CD30 (TNFRSF8) Protein Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas CD30 (TNFRSF8) Protein Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC CD30 (TNFRSF8) Protein Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC CD30 (TNFRSF8) Protein Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe CD30 (TNFRSF8) Protein Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe CD30 (TNFRSF8) Protein Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa CD30 (TNFRSF8) Protein Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa CD30 (TNFRSF8) Protein Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global CD30 (TNFRSF8) Protein Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global CD30 (TNFRSF8) Protein Sales Market Share Forecast by Type (2023-2028)
Table 89. Global CD30 (TNFRSF8) Protein Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global CD30 (TNFRSF8) Protein Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global CD30 (TNFRSF8) Protein Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global CD30 (TNFRSF8) Protein Sales Market Share Forecast by Application (2023-2028)
Table 93. Global CD30 (TNFRSF8) Protein Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global CD30 (TNFRSF8) Protein Revenue Market Share Forecast by Application (2023-2028)
Table 95. Sino Biological, Inc. Basic Information, CD30 (TNFRSF8) Protein Manufacturing Base, Sales Area and Its Competitors
Table 96. Sino Biological, Inc. CD30 (TNFRSF8) Protein Product Offered
Table 97. Sino Biological, Inc. CD30 (TNFRSF8) Protein Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. Sino Biological, Inc. Main Business
Table 99. Sino Biological, Inc. Latest Developments
Table 100. Bio-Techne Basic Information, CD30 (TNFRSF8) Protein Manufacturing Base, Sales Area and Its Competitors
Table 101. Bio-Techne CD30 (TNFRSF8) Protein Product Offered
Table 102. Bio-Techne CD30 (TNFRSF8) Protein Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Bio-Techne Main Business
Table 104. Bio-Techne Latest Developments
Table 105. Elabscience Biotechnology Inc. Basic Information, CD30 (TNFRSF8) Protein Manufacturing Base, Sales Area and Its Competitors
Table 106. Elabscience Biotechnology Inc. CD30 (TNFRSF8) Protein Product Offered
Table 107. Elabscience Biotechnology Inc. CD30 (TNFRSF8) Protein Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Elabscience Biotechnology Inc. Main Business
Table 109. Elabscience Biotechnology Inc. Latest Developments
Table 110. Abbexa Basic Information, CD30 (TNFRSF8) Protein Manufacturing Base, Sales Area and Its Competitors
Table 111. Abbexa CD30 (TNFRSF8) Protein Product Offered
Table 112. Abbexa CD30 (TNFRSF8) Protein Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Abbexa Main Business
Table 114. Abbexa Latest Developments
Table 115. MyBiosource, Inc. Basic Information, CD30 (TNFRSF8) Protein Manufacturing Base, Sales Area and Its Competitors
Table 116. MyBiosource, Inc. CD30 (TNFRSF8) Protein Product Offered
Table 117. MyBiosource, Inc. CD30 (TNFRSF8) Protein Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. MyBiosource, Inc. Main Business
Table 119. MyBiosource, Inc. Latest Developments
Table 120. OriGene Technologies, Inc. Basic Information, CD30 (TNFRSF8) Protein Manufacturing Base, Sales Area and Its Competitors
Table 121. OriGene Technologies, Inc. CD30 (TNFRSF8) Protein Product Offered
Table 122. OriGene Technologies, Inc. CD30 (TNFRSF8) Protein Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. OriGene Technologies, Inc. Main Business
Table 124. OriGene Technologies, Inc. Latest Developments
Table 125. Prospec-Tany Technogene Ltd. Basic Information, CD30 (TNFRSF8) Protein Manufacturing Base, Sales Area and Its Competitors
Table 126. Prospec-Tany Technogene Ltd. CD30 (TNFRSF8) Protein Product Offered
Table 127. Prospec-Tany Technogene Ltd. CD30 (TNFRSF8) Protein Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. Prospec-Tany Technogene Ltd. Main Business
Table 129. Prospec-Tany Technogene Ltd. Latest Developments
Table 130. KACTUS Basic Information, CD30 (TNFRSF8) Protein Manufacturing Base, Sales Area and Its Competitors
Table 131. KACTUS CD30 (TNFRSF8) Protein Product Offered
Table 132. KACTUS CD30 (TNFRSF8) Protein Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. KACTUS Main Business
Table 134. KACTUS Latest Developments
Table 135. G&P Biosciences Basic Information, CD30 (TNFRSF8) Protein Manufacturing Base, Sales Area and Its Competitors
Table 136. G&P Biosciences CD30 (TNFRSF8) Protein Product Offered
Table 137. G&P Biosciences CD30 (TNFRSF8) Protein Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 138. G&P Biosciences Main Business
Table 139. G&P Biosciences Latest Developments
Table 140. ACROBiosystems Basic Information, CD30 (TNFRSF8) Protein Manufacturing Base, Sales Area and Its Competitors
Table 141. ACROBiosystems CD30 (TNFRSF8) Protein Product Offered
Table 142. ACROBiosystems CD30 (TNFRSF8) Protein Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 143. ACROBiosystems Main Business
Table 144. ACROBiosystems Latest Developments
Table 145. Assay Genie Basic Information, CD30 (TNFRSF8) Protein Manufacturing Base, Sales Area and Its Competitors
Table 146. Assay Genie CD30 (TNFRSF8) Protein Product Offered
Table 147. Assay Genie CD30 (TNFRSF8) Protein Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 148. Assay Genie Main Business
Table 149. Assay Genie Latest Developments
Table 150. ZellBio GmbH Basic Information, CD30 (TNFRSF8) Protein Manufacturing Base, Sales Area and Its Competitors
Table 151. ZellBio GmbH CD30 (TNFRSF8) Protein Product Offered
Table 152. ZellBio GmbH CD30 (TNFRSF8) Protein Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 153. ZellBio GmbH Main Business
Table 154. ZellBio GmbH Latest Developments
List of Figures
Figure 1. Picture of CD30 (TNFRSF8) Protein
Figure 2. CD30 (TNFRSF8) Protein Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global CD30 (TNFRSF8) Protein Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global CD30 (TNFRSF8) Protein Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. CD30 (TNFRSF8) Protein Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Purity : Greater Than 85%
Figure 10. Product Picture of Purity : Greater Than 90%
Figure 11. Product Picture of Purity : Greater Than 95%
Figure 12. Product Picture of Purity : Greater Than 97%
Figure 13. Product Picture of Other
Figure 14. Global CD30 (TNFRSF8) Protein Sales Market Share by Type in 2021
Figure 15. Global CD30 (TNFRSF8) Protein Revenue Market Share by Type (2017-2022)
Figure 16. CD30 (TNFRSF8) Protein Consumed in SDS-PAGE
Figure 17. Global CD30 (TNFRSF8) Protein Market: SDS-PAGE (2017-2022) & (K Units)
Figure 18. CD30 (TNFRSF8) Protein Consumed in ELISA
Figure 19. Global CD30 (TNFRSF8) Protein Market: ELISA (2017-2022) & (K Units)
Figure 20. CD30 (TNFRSF8) Protein Consumed in Other
Figure 21. Global CD30 (TNFRSF8) Protein Market: Other (2017-2022) & (K Units)
Figure 22. Global CD30 (TNFRSF8) Protein Sales Market Share by Application (2017-2022)
Figure 23. Global CD30 (TNFRSF8) Protein Revenue Market Share by Application in 2021
Figure 24. CD30 (TNFRSF8) Protein Revenue Market by Company in 2021 ($ Million)
Figure 25. Global CD30 (TNFRSF8) Protein Revenue Market Share by Company in 2021
Figure 26. Global CD30 (TNFRSF8) Protein Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global CD30 (TNFRSF8) Protein Revenue Market Share by Geographic Region in 2021
Figure 28. Global CD30 (TNFRSF8) Protein Sales Market Share by Region (2017-2022)
Figure 29. Global CD30 (TNFRSF8) Protein Revenue Market Share by Country/Region in 2021
Figure 30. Americas CD30 (TNFRSF8) Protein Sales 2017-2022 (K Units)
Figure 31. Americas CD30 (TNFRSF8) Protein Revenue 2017-2022 ($ Millions)
Figure 32. APAC CD30 (TNFRSF8) Protein Sales 2017-2022 (K Units)
Figure 33. APAC CD30 (TNFRSF8) Protein Revenue 2017-2022 ($ Millions)
Figure 34. Europe CD30 (TNFRSF8) Protein Sales 2017-2022 (K Units)
Figure 35. Europe CD30 (TNFRSF8) Protein Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa CD30 (TNFRSF8) Protein Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa CD30 (TNFRSF8) Protein Revenue 2017-2022 ($ Millions)
Figure 38. Americas CD30 (TNFRSF8) Protein Sales Market Share by Country in 2021
Figure 39. Americas CD30 (TNFRSF8) Protein Revenue Market Share by Country in 2021
Figure 40. United States CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC CD30 (TNFRSF8) Protein Sales Market Share by Region in 2021
Figure 45. APAC CD30 (TNFRSF8) Protein Revenue Market Share by Regions in 2021
Figure 46. China CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 50. India CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe CD30 (TNFRSF8) Protein Sales Market Share by Country in 2021
Figure 53. Europe CD30 (TNFRSF8) Protein Revenue Market Share by Country in 2021
Figure 54. Germany CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 55. France CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa CD30 (TNFRSF8) Protein Sales Market Share by Country in 2021
Figure 60. Middle East & Africa CD30 (TNFRSF8) Protein Revenue Market Share by Country in 2021
Figure 61. Egypt CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country CD30 (TNFRSF8) Protein Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of CD30 (TNFRSF8) Protein in 2021
Figure 67. Manufacturing Process Analysis of CD30 (TNFRSF8) Protein
Figure 68. Industry Chain Structure of CD30 (TNFRSF8) Protein
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets